I think it's worse than burned or let down. I don't think investors can trust the board.
Their position that they will make direction clearer at the AGM isn't good enough.
It absolutely screams that right now they don't have a direction. Worse is that they have committed to spending $5 million this quarter - the lions share of which on a 50(?) patient agitation study - unsure if agitation or 210 is even a way forward. Oh and Deborah is going to take home $125K during the quarter, of which for at least half she is working without direction.
It has taken an appaling amount of time to do anything with the oncology assets.
The oncology assets alone should be enough to convince investors that they haven't changed when it comes to communication.
Deborah's MIA status since the start of October has really driven it home that she could care less about Australian retail holders.
Hope a reasonable amount of votes are received against the remuneration report.
Prediction still stands that she is going to pull an awful maneuver like write off the PTSD study ($30 mill ?) and in the second half of November we are going to be sitting at $0.05.